Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Study of ASP2151 in Herpes Simplex Patients
jRCT2080222573Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Amenamevir in herpes labialis, genital herpes and eczema herpeticum (EH) (3 arms), sponsored by Maruho Co., Ltd. Started Aug 2014; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes labialisgenital herpeseczema herpeticum (EH)
Beyond the preview
Go deeper on jRCT2080222573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222573.